Original articles

• A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype

  Marta Alonso-Fernández-Gatta, María Gallego-Delgado, Ricardo Caballero, Eduardo Villacorta, Elena Díaz-Peláez, Belén García-BerrocaL, Teresa Crespo-García, Beatriz Plata-Izquierdo, Elena Marcos-Vadillo, Luisa García-Cuenllas, Manuel Barreiro-Pérez, María Isidoro-García, Juan Tamargo-Menéndez, Eva Delpón, Pedro L. Sánchez

  Rev Esp Cardiol. 2021;74:781-9

• Is the pace of decline in cardiovascular mortality decelerating in Spain?

  Lucía Cayuela, Sara Gómez Enjuto, Blanca Olivares Martínez, Susana Rodríguez-Domínguez, Aurelio Cayuela

  Rev Esp Cardiol. 2021;74:750-6

• Cost and burden of poor anticoagulation control with vitamin K antagonists in patients with nonvalvular atrial fibrillation in Spain

  Vivencio Barrios, Sergio Cinza-Sanjurjo, Olga Gavín, Isabel Egocheaga, Ramón Burgos-Pol, Javier Soto, Carlos Polanco, Jorge Suárez, Miguel Ángel Casado

  Rev Esp Cardiol. 2021;74:773-80

• Temporal trends in postinfarction ventricular septal rupture: the CIVIAM Registry

  Juan Diego Sánchez Vega, Gonzalo Luis Alonso Salinas, José María Viéitez Flórez, Albert Ariza Solé, Esteban López de Sá, Ricardo Sanz Ruiz, Virginia Burgos Palacios, Sergio Raposeiras-Roubín, Susana Gómez Varela, Juan Sanchis, Lorenzo Silva Melchor, Xurxo Martínez-Seara, Lorena Malagón López, José Luis Zamorano Gómez, Marcelo Sanmartín Fernández, for the CIVIAM Study Investigators

  Rev Esp Cardiol. 2021;74:757-64

• Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

  Juan Sanchis, Jose María García Acuña, Sergio Raposeiras, Jose A. Barrabés, Alberto Cordero, Manuel Martínez-Sellés, Alfredo Bardají, Pablo Díez-Villanueva, Francisco Marín, Juan M. Ruiz-Nodar, Nuria Vicente-Ibarra, Gonzalo L. Alonso Salinas, Pedro Rigueiro, Emad Abu-Assi, Frances Formiga, Julio Núñez, Eduardo Núñez, Albert Ariza-Solé

  Rev Esp Cardiol. 2021;74:765-72

• Isolated aortic valve replacement in Spain: national trends in risks, valve types, and mortality from 1998 to 2017

  Manuel Carnero-Alcázar, Luis Carlos Maroto-Castellanos, Daniel Hernández-Vaquero, José López-Menéndez, Fernando Hornero-Sos, Jacobo Silva-Guisasola, Javier Cobiella-Carnicer, Daniel Pérez-Camargo, María Arantzatzu Álvarez-de Arcaya, Paula Campelos-Fernández, Carlos Elvira-Martínez

  Rev Esp Cardiol. 2021;74:700-7

• Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia

  Itziar Lamiquiz-Moneo, Fernando Civeira, Rocío Mateo-Gallego, Martín Laclaustra, Belén Moreno-Franco, María Teresa Tejedor, Lourdes Palacios, César Martín, Ana Cenarro

  Rev Esp Cardiol. 2021;74:664-73

• Predictors of cardiovascular outcomes after surgery in severe tricuspid regurgitation: clinical, imaging and hemodynamic prospective study

  José F. Rodríguez-Palomares, Jordi Lozano-Torres, Ilaria Dentamaro, Filipa X. Valente, Augusto Sao Avilés, Laura Gutiérrez García-Moreno, Pau Rello Sabaté, Imanol Otaegui, Beatriz Mínguez Rosique, Hug Cuéllar Calabria, Artur Evangelista Masip, Pilar Tornos Mas, Ignacio Ferreira-González, María Teresa González-Alujas

  Rev Esp Cardiol. 2021;74:655-63

• Optimal strategy for side branch treatment in patients with left main coronary bifurcation lesions

  Jihoon Kim, Joo Myung Lee, Taek Kyu Park, Jeong Hoon Yang, Joo-Yong Hahn, Jin-Ho Choi, Seung-Hyuk Choi, Ki Bae Seung, Seung-Ho Hur, Seung-Woon Rha, June-Hong Kim, Rak Kyeong Choi, Ju Hyeon Oh, Hyo-Soo Kim, Seung-Hwan Lee, Jong-Seon Park, Sung Yun Lee, Dong Woon Jeon, Myung Ho Jeong, Jae-Hwan Lee, Sang Yeub Lee, Woo-Jung Park, Young Bin Song, Hyeon-Cheol Gwon

  Rev Esp Cardiol. 2021;74:691-9

• Differences in 30-day complications and 1-year mortality by sex in patients with a first STEMI managed by the Codi IAM network between 2010 and 2016

  Helena Tizón-Marcos, Beatriz Vaquerizo, Jaume Marrugat, Albert Ariza, Xavier Carrillo, Juan-Francisco Muñoz, Mérida Cárdenas, Joan García-Picart, Sergio-Giovanni Rojas, Carlos Tomás-Querol, Mònica Massotti, Rosa-Maria Lidón, Josep Jiménez, Julio Martí-Almor, Núria Farré, Sílvia Pérez-Fernández, Antoni Curós, Josepa Mauri Ferré

  Rev Esp Cardiol. 2021;74:674-81

• Prognostic implications of coronary physiological indices in patients with diabetes mellitus

  Doyeon Hwang, Jinlong Zhang, Joo Myung Lee, Joon-Hyung Doh, Chang-Wook Nam, Eun-Seok Shin, Masahiro Hoshino, Tadashi Murai, Taishi Yonetsu, Hernán Mejía-Rentería, Tsunekazu Kakuta, Javier Escaned, Bon-Kwon Koo

  Rev Esp Cardiol. 2021;74:682-90

• The RITHMI study: diagnostic ability of a heart rhythm monitor for automatic detection of atrial fibrillation

  Joaquín Osca Asensi, María Teresa Izquierdo de Francisco, Óscar Cano Pérez, María José Sancho Tello de Carranza, José Alberola Rubio, Carlos Planells Palop, José Vicente Lozano Vidal, Luis Martínez Dolz

  Rev Esp Cardiol. 2021;74:602-7

• Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

  Aitor Uribarri, Iván J. Núñez-Gil, Álvaro Aparisi, Ramón Arroyo-Espliguero, Charbel Maroun Eid, Rodolfo Romero, Víctor M. Becerra-Muñoz, Gisela Feltes, María Molina, Marcos García-Aguado, Enrico Cerrato, Thamar Capel-Astrua, Emilio Alfonso-Rodríguez, Alex F. Castro-Mejía, Sergio Raposeiras-Roubín, Carolina Espejo, Nerea Pérez-Solé, Alfredo Bardají, Francisco Marín, Óscar Fabregat-Andrés, Fabrizio D’ascenzo, Francesco Santoro, Ibrahim Akin, Vicente Estrada, Antonio Fernández-Ortiz, Carlos Macaya, on behalf of HOPE COVID-19 investigators

  Rev Esp Cardiol. 2021;74:608-15

• Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction

  Rafael de la Espriella, Eduardo Núñez, Pau Llàcer, Sergio García-Blas, Silvia Ventura, José María Núñez, Ruth Sánchez, Lorenzo Fácila, Juana María Vaquer, Vicent Bodí, Enrique Santas, Gema Miñana, Anna Mollar, Gonzalo Núñez, Francisco J. Chorro, José L. Górriz, Juan Sanchis, Antoni Bayés-Genis, Julio Núñez

  Rev Esp Cardiol. 2021;74:616-23

• Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice

  Jens Wiebe, Petra Hoppmann, Salvatore Cassese, Tobias Rheude, Roisin Colleran, Constantin Kuna, Himanshu Rai, Michael Valeskini, Tareq Ibrahim, Michael Joner, Heribert Schunkert, Karl-Ludwig Laugwitz, Adnan Kastrati, Robert A. Byrne

  Rev Esp Cardiol. 2021;74:584-90

• Spanish registry of percutaneous VSD closure with NitOcclud Lê VSD Coil device: lessons learned after more than a hundred implants

  Ruth Solana-Gracia, Alberto Mendoza Soto, José Ignacio Carrasco Moreno, María Jesús del Cerro Marín, Federico Gutiérrez-Larraya Aguado, José Félix Coserría Sánchez, Roberto Blanco Mata, Fredy Hermógenes Prada Martínez, Manuel Pan Álvarez-Ossorio, Lorenzo Jiménez Montañés, Armando Pérez de Prado, María del Mar Rodríguez Vázquez del Rey, Hipólito Gutiérrez García, José Manuel Velasco Bayón, José Luis Zunzunegui Martínez

  Rev Esp Cardiol. 2021;74:591-601

• Markers of myocardial injury in the prediction of short-term COVID-19 prognosis

  Alicia Calvo-Fernández, Andrea Izquierdo, Isaac Subirana, Nuria Farré, Joan Vila, Xavier Durán, Marcos García-Guimaraes, Sandra Valdivielso, Paula Cabero, Cristina Soler, Cora García-Ribas, Clara Rodríguez, Marc Llagostera, Diana Mojón, Miren Vicente, Eduard Solé-González, Andrea Sánchez-Carpintero, Cristina Tevar, Jaume Marrugat, Beatriz Vaquerizo

  Rev Esp Cardiol. 2021;74:576-83

• Reasons for refusing diagnostic tests and therapeutic recommendations and associated complications in inherited heart diseases. The RELUCTANT study

  David López Cuenca, María Orenes Moreno, M. Carmen Olmo Conesa, Antonio Pastor Moreno, Juan José Santos Mateo, Carmen Muñoz Esparza, Marina Navarro Peñalver, Francisco José Castro García, María Sabater Molina, Juan Ramón Gimeno Blanes

  Rev Esp Cardiol. 2021;74:526-32

• Noninferiority of heart failure nurse titration versus heart failure cardiologist titration. ETIFIC multicenter randomized trial

  Juana Oyanguren, Lluisa Garcia-Garrido, Magdalena Nebot-Margalef, Pedro Latorre-García, Jesús Torcal-Laguna, Josep Comín-Colet, Julia Roure, José González-Costello, Nicolás Manito, José M. García-Pinilla, Yolanda Sánchez-Paule, Alfonso Varela-Román, María Moure, Javier Segovia-Cubero, Teresa Soria, Eunate Arana-Arri, Iñaki Lekuona, Steering Committee on behalf of the ETIFIC research team group

  Rev Esp Cardiol. 2021;74:533-43

• Feasibility and results of an intensive cardiac rehabilitation program. Insights from the MxM (Más por Menos) randomized trial

  Almudena Castro-Conde, Manuel Abeytua, Vicente I. Arrarte Esteban, Pedro Caravaca Pérez, Regina Dalmau González-Gallarza, Fernando Garza Benito, Rafael J. Hidalgo Urbano, Joan Torres Marqués, Rafael Vidal-Pérez, Iván J. Nuñez-Gil

  Rev Esp Cardiol. 2021;74:518-25